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Abstract
Background: Genetic variants in TRAF1C5 and PTPN22 genes have been shown to be significantly associated with
arthritis rheumatoid in Caucasian populations. This study investigated the association between single nucleotide
polymorphisms (SNPs) in TRAF1/C5 and PTPN22 genes and rheumatoid arthritis (RA) in a Han Chinese population.
We genotyped SNPs rs3761847 and rs7021206 at the TRAF1/C5 locus and rs2476601 SNP in the PTPN22 gene in a
Han Chinese cohort composed of 576 patients with RA and 689 controls. The concentrations of anti-cyclic
citrullinated peptide antibodies (CCP) and rheumatoid factor (RF) were determined for all affected patients. The
difference between the cases and the controls was compared using χ
2 analysis.
Results: Significant differences in SNPs rs3761847 and rs7021206 at TRAF1/C5 were observed between the case and
control groups in this cohort; the allelic p-value was 0.0018 with an odds ratio of 1.28 for rs3761847 and 0.005 with
an odds ratio of 1.27 for rs7021206. This significant association between rs3761847 and RA was independent of the
concentrations of anti-CCP and RF. No polymorphism of rs2476601 was observed in this cohort.
Conclusions: We first demonstrated that genetic variants at the TRAF1/C5 locus are significantly associated with RA
in Han Chinese, suggesting that TRAF1/C5 may play a role in the development of RA in this population, which
expands the pathogenesis role of TRAF1/C5 in a different ethnicity.
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Background
Rheumatoid arthritis (RA) is a chronic inflammatory
disease that affects about 1% of the adult Caucasian
population and 0.37% of the Chinese population.
Women are affected three times more often than men
[1-3]. This disease may affect many tissues and organs;
it particularly destroys synovial joints involving autoim-
mune features [2]. The disease can cause severe disabil-
ity and even early mortality.
Although the full etiology of RA remains unclear, it is
considered a complex disease caused by the interaction
of genetic variants, the environment, infectious and hor-
monal factors [4]. The genetic variants may contribute
50-60% of the etiology of RA [5]. At least 31 RA risk
loci have been confirmed associated with RA in different
populations [6-14]. At TRAF1/C5 locus, both TRAF1
and C5 are possible RA-causing genes due to their bio-
logical functions. TNF is a critical cytokine in the patho-
genesis of RA [15]. TRAF1 and TRAF2 form a
heterodimeric complex, which is required for TNF-
alpha-mediated activation of MAPK8/JNK and NF-kap-
paB. The protein complex formed by this protein and
TRAF2 also interacts with inhibitor-of-apoptosis pro-
teins (IAPs), and thus mediates the anti-apoptotic sig-
nals from TNF receptors. TNF antagonists are an
effective treatment for rheumatoid arthritis [15-17]. On
the other hand, the clinical and biological data for C5
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has been implicated in the pathogenesis of RA for a
long time [18,19]. Complement activation leading to sig-
nificant depletion of complement components has been
shown in synovial fluid of patients with RA [15].
rs7021206 is located at TRAF1 intron 3 and rs3761847
is located at the upstream of TRAF1 and the down
stream of C5. These variants or other causative variants
at this locus may affect the function or expression levels
of TRAF1 and/or C5 to lead to RA.
In this study, we investigated the association between
rs7021206 and rs3761847 at the TRAF1/C5 locus and




The Institutional Review Boards of the Sichuan Acad-
emy of Medical Sciences & Provincial People’s Hospital,
North Sichuan Medical College, China, approved this
study. All subjects provided informed consent before
participating in the study. RA patients and normal
matched controls, including individuals with a normal
joint examination, were recruited at the rheumatology
and Immunology clinics at Sichuan Provincial People’s
Hospital and North Sichuan Medical College, China. All
participants went through a standard examination pro-
tocol as noted in the previous description: (http://med-
calc3000.com/RheumatoidArthritis.htm, Rheumatoid
Arthritis Criteria 1987 revision, American Rheumatism
Association), including morning stiffness, arthritis of
three or more joints, including hand joints, symmetric
arthritis, rheumatoid nodules, serum rheumatoid factor,
and radiographic changes. In total, 576 patients with RA
and 689 normal age-matched controls were recruited.
All patients enrolled in this study at least two years after
clinical diagnosis of RA and the patients had five years
of mean disease duration. In the normal controls, no
sign of joint or other autoimmune disease was detected.
Clinical information about the cases and controls is
listed in Table 1.
CCP and RF measurement
Sera were obtained and tested for concentrations of RF
and anti-CCP in all patients. The concentrations of anti-
CCP antibodies were detected with an Anti-CCP-ELISA
kit (EUROIMMUN Medizinische Labordiagnostika AG,
Lübeck, Germany) on a Bio Rad Bench Mark machine
(Rio Rad, Hercules, CA, USA). RF was determined with
an endpoint nephelometry kit (Siemens Healthcare
Diagnostics Products GmbH, Marburg, Germany) on a
DADE BEHRING BNII machine (GMI, Minnesota,
USA) according to the manufacturer’sm a n u a li n s t r u c -
tions. Results were corroborated by validation at the
clinical laboratory of Sichuan Provincial People’s Hospi-
tal, Sichuan, China. Cases with anti-CCP levels higher
than 20units/ml were considered positive for anti-CCP
antibodies; cases with RF levels higher than 5 units/ml
were considered positive for RF.
Genotyping
Based on previous genome-wide association studies
(GWAS) and replication studies in Asians [6-13,20], we
selected rs7021206 and rs3761847 at the TRAF1/C5
locus and rs2476601 in the PTPN22 gene to genotype in
the Han Chinese population. Venous blood from each
subject was withdrawn and collected in an EDTA tube.
Genomic DNA was extracted from the blood by serial
phenol/chloroform extraction and ethanol precipitation.
SNP genotyping was performed with the dye termina-
tor-based SNaPshot method (Applied Biosystems, CA,
USA). The SNP reported in this manuscript has a geno-
typing success rate of 97% and accuracy as judged by
random re-genotyping of 10% of the samples in the
cohort. For rs3761847, the PCR forward primer 5’-
CCTACCTGTTCCCTCCTTCC-3’, PCR reverse primer
5’-GGGATGATGATGGCAATACC-3’,a n dS N a P s h o t
primer 5’- AGGTAGAGAGGGTGGTATTGAGGC-3’
were used in genotyping. For rs7021206, the PCR for-
ward primer 5’-GAGAAGCAGATGGGAGAGTG-3’,
PCR reverse primer 5’-TGCTTGGCTAGCAG-
CAATTC-3’,a n dS N a P s h o tp r i m e r5 ’-AAGGAGAAG-
GAGGTGTGGACACTCGCCTGCCTCTGGTCCA-3’
were used in genotyping. For rs2476601, the PCR for-
ward primer 5’- GGCCTCAATGAACTCCTCAA-3’,
PCR reverse primer 5’- GGATAGCAACTGCTC-
CAAGG-3’a n dS N a P s h o tp r i m e r5 ’-CCTCAACCACAA-
TAAATGATTCAGGTGTCC-3’ were used in
genotyping.
Statistical analysis
The Hardy-Weinberg equilibrium (HWE) for the SNP
was tested with the c
2 test. All analyses were adjusted
for matching factors of age and sex factors. Allele and
Table 1 Characteristics of RA cases and controls matched for ages and ethnicity
Subject Total number anti-CCP positive RF positive Male Female Average age
Cases 576 363 496 266 310 64 ± 6.6
Controls 689 0 0 307 382 65 ± 7.8
± represents standard deviation.
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compared with the c
2 analysis. Statistical significance
was defined as p < 0.05. All statistical analyses were per-
formed using the software SPSS version 10.0.
Results
Among the 576 patients with RA, 363 of them were
anti-CCP positive and 496 of them were RF positive
(Table 1). Linkage disequlibrium between rs3761847 and
rs7021206 was 0.23 (r
2) in the Chinese cohort studied.
Allele distributions both of rs3761847 and rs7021206
were within the Hardy-Weinberg equilibrium in both
the case and control groups (p > 0.05, Table 2). We
found that both rs3761847 and rs7021206 were signifi-
cantly associated with RA in the cohort studied (Allelic
p = 0.0018, adjusted p = 0.054 for rs3761847; allelic p =
0.005, adjusted p = 0.015 for rs7021206, Table 2). For
rs3761847, the risk allele frequency was 0.58 in the
patients and 0.52 in the controls. The risk allele of this
SNP conferred a 1.28-fold (95% CI: 1.10~1.50) increased
likelihood of RA (Table 2). For rs7021206, the risk allele
frequency was 0.34 in the patients and 0.29 in the con-
trols. The risk allele of this SNP conferred a 1.27-fold
(95% CI: 1.07~1.50) increased likelihood of RA (Table
2). rs3761847 showed significant association with RA in
both the anti-CCP positive and anti-CCP negative
groups. The p value is 0.0015 in the anti-CCP positive
group with an odds ratio (OR) of 1.33 (95% CI: 1.11-
1.60; Table 3); the p value is 0.043 in the anti-CCP
negative group with an OR of 1.25 (95% CI: 1.0-1.56;
Table 3). rs3761847 also showed a significant association
with RA in both the RF positive and negative groups.
The p value was 0.0015 in the RF positive group with
an OR of 1.30 (95% CI: 1.10-1.53; Table 3); the p value
was 0.03 in the RF negative group with an OR of 1.44
(95% CI: 1.03-2.01; Table 3). rs7021206 also showed sig-
nificant association with RA in both the anti-CCP
positive and RF positive groups, (p = 2.5 × 10
-4 and 1.4
×1 0
-4, respectively, table 3), but not in anti-CCP or RF
negative groups (p = 0.065, 0.29, respectively, table 3).
No polymorphism was observed for rs2476601 in the
cohort.
Discussion
Although at least 31 susceptibility loci/genes responsible
for RA have been identified [14]; including HLA-DRB1
([7,13], protein tyrosine phosphatase 22 (PTPN22)g e n e
[13,21], tumor necrosis factor, alpha-induced protein 3
(TNFAIP3) locus on chromosome 6q [8,9,13], TRAF1/
C5 [10,11], STAT4 [12], interferon regulatory factor 5
isoform a (IRF5) [22], peptidylarginine deiminase
(PADI4)[ 2 3 ] ,CD244 natural killer cell receptor 2B4
(CD244)[ 2 4 ] ,CD40 antigen isoform 2 precursor (CD40)
[25], small inducible cytokine A21 precursor (CCL21)
[25], and solute carrier family 22 member 4 (SLC22A4)
[26] and others [14], only 5 loci/genes (HLA, PTPN22,
TRAF1/C5, TNFAIP3,a n dSTAT4) have been success-
fully replicated in different ethnicities, whereas others
have been observed less systematically or further replica-
tion studies in different ethnicities are needed. Among
the five successfully replicated loci, HLA showed a sig-
nificant association with RA in all different ethnicities.
The association of STAT4 with RA has also been suc-
cessfully replicated in Asians, including Japanese, Kor-
eans and Chinese [27-29]; and the association of
TRAF1/C5 with RA has also been replicated in Japanese
and Korean populations [20,30].
Although rs2476601 (R620W) in PTPN22 has been
constantly associated with RA in populations of Eur-
opean descent, including US [31], UK [32], Finnish [33],
Swedish [34], German [35], Dutch [36], Spanish [37],
and Canadian [38] populations, this SNP did not show a
significant association with RA in the Japanese popula-
tion [39] studied because there is a very low minor allele
Table 2 Association between rs3761847 and rs7021206 in TRAF1/C5 and RA in a Han Chinese cohort
SNP Phenotype HWE Genotype count (frequency) Allele frequency Allelic p Adjusted p OR (95%CI)
Case (576) 0.93 AA: 192 (0.33) A:0.58 0.0018 0.0054 1.28 (1.10-1.50)
AG: 282 (0.49) G:0.42
rs3761847 GG: 102 (0.18)
Control (689) 0.06 AA: 171 ( 0.25) A:0.52
AG: 369 ( 0.54) G:0.48
GG:149 ( 0.21)
Case (576) 0.07 AA: 239 (0.41) A:0.66 0.005 0.015 1.27 (1.07-1.50)
AG: 279 (0.48) G:0.34
rs7021206 GG: 58 (0.11)
Control (689) 0.54 AA: 343 (0.50 ) A:0.71
AG: 291 (0.42 ) G:0.29
GG: 55 ( 0.08 )
SNP: single nucleotide polymorphism, HWE: Hardy-Weinberg equilibrium, OR: odds ratio, CI: confidence interval.
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SNPs covering the PTPN22 linkage disequilibrium block
were polymorphic in the Korean population, Lee et al
did not reveal any disease association, and the re-
sequencing did not identify any new common coding
region variants in this population [40]. Consistent with
results in Japanese and Korean populations, we did not
find even a single minor allele of rs2476601 in the stu-
died Chinese cohort, suggesting that rs2476601 in
PTPN22 is not associated with RA in Asians.
On the other hand, genetic variants in PADI4 have
shown significant association with RA in Asian popula-
tions [24,41,42] but not in Caucasian populations
[34,43]. Therefore, we believe the genetics of RA shows
obvious ethnic differences.
rs3761847 at the TRAF1/C5 locus has been signifi-
cantly associated with RA in an initial genome-wide
association study (GWAS) in a North American and
Swedish cohort, composed of 1493 cases and 1831 con-
trols [11]. This finding was replicated in the second
cohort composed of 485 cases and 1282 controls in a
N o r t hA m e r i c a np o p u l a t i o n[ 1 1 ] .I na d d i t i o n ,u s i n ga
candidate gene approach, Kurreeman et al identified
that rs10818488 in TRAF1/C5 is significantly associated
with RA in patients of Dutch origin [10]. This finding
was confirmed in a case-control study in the population
of the island of Crete, Greece [44] and a meta-analysis
[45]. Kurreeman et al also confirmed the TRAF1/C5
locus as a susceptibility locus for rheumatoid arthritis in
a European family-based replication study using
rs10818488 at this region [46]. However, this association
could not be confirmed in a Swedish cohort composed
of 568 cases and 516 controls. Chang et al [15], carried
out a multi-tiered, case-controlled association study,
genotyping 25,966 putative functional SNPs in an initial
North America cohort, composed of 475 cases and 475
controls and two replication cohorts (661 cases/1322
controls from North America and 596 cases/705 con-
trols from the Netherlands). The authors identified an
SNP, rs1953126 at the TRAF1/C5 locus that was signifi-
cantly associated with RA (OR = 1.28, trend p = 1.45 ×
10
-6). Through a comprehensive fine-scale-mapping
study, they found a variety of analyses identified SNPs
in a 70 kb region extending from the third intron of
PHF19 across TRAF1 into the TRAF1-C5 intergenic
region, excluding the C5 coding region. This study
Table 3 Association of rs3761847 and rs7021206 in TRAF1/C5 and subgroup RA in a Han Chinese cohort
SNP Group HWE Genotype count and frequency Allele frequency Allelic p OR (95%CI)
Case (frequency) Control (frequency) Case Control
anti-CCP positive Case: 0.76 AA:127 (0.35) AA:171 ( 0.25) A: 0.59 A: 0.52 0.0015 1.33 (1.11-1.60)
Control: 0.058
AG:173 (0.48) AG:369 ( 0.54) G: 0.41 G: 0.48
GG:63 (0.17) GG:149 ( 0.21)
anti-CCP negative Case: 0.81 AA:69 (0.32) AA:171 ( 0.25) A: 0.57 A: 0.52 0.040 1.25 (1.01-1.56)
Control: 0.058 AG:106 (0.50) AG:369 ( 0.54) G: 0.43 G: 0.48
rs3761847 GG:38 (0.18) GG:149 ( 0.21)
RF positive Case: 0.81 AA:170 (0.34) AA:171 ( 0.25) A: 0.58 A: 0.52 0.0015 1.30 (1.10-1.53)
Control: 0.058 AG:237 (0.48) AG:369 ( 0.54) G: 0.42 G: 0.48
GG:89 (0.18) GG:149 ( 0.21)
RF negative Case: 0.26 AA:27 (0.34) AA:171 ( 0.25) A: 0.61 A: 0.52 0.030 1.44 (1.03-2.01)
Control: 0.058 AG:43 (0.54) AG:369 ( 0.54) G: 0.39 G: 0.48
GG:10 (0.16) GG:149 ( 0.21)
anti-CCP positive Case: 0.22 AA:139 (0.38 ) AA:343 (0.50 ) G: 0.37 G: 0.29 0.00025 1.42 (1.18-1.72)
Control: 0.54 AG:180 (0.50 ) AG:291 (0.42 ) A: 0.63 A: 0.71
GG:44 (0.12 ) GG:55 ( 0.08 )
anti-CCP negative Case: 0.18 AA:89 (0.42 ) AA:343 (0.50 ) G: 34 G: 0.29 0.065
Control: 0.54 AG:104 (0.49 ) AG:291 (0.42 ) A: 0.66 A: 0.71
rs7021206 GG:20 (0.09 ) GG:55 ( 0.08 )
RF positive Case: 0.17 AA:193 (0.39 ) AA:343 (0.50 ) G: 0.36 G: 0.29 0.00014 1.40 (1.18-1.67)
Control: 0.54 AG:244 (0.49 ) AG:291 (0.42 ) A: 0.64 A: 0.71
GG:59 (0.12 ) GG:55 ( 0.08 )
RF negative Case: 0.26 AA:38 (0.48) AA:343 (0.50 ) G: 0.33 G: 0.29 0.29
Control: 0.54 AG:31 (0.39) AG:291 (0.42 ) A: 0.67 A: 0.71
GG:11 ( 0.13 ) GG:55 ( 0.08 )
SNP: single nucleotide polymorphism, HWE: Hardy-Weinberg equilibrium, OR: odds ratio, CI: confidence interval.
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locus, but further studies are needed to confirm this
conclusion.
In recent studies, rs3761847 has been shown to be sig-
nificantly associated with RA in Japanese [30]. Our
results further confirmed that rs3761847 at the TRAF1/
C5 was associated with RA in Han Chinese Asians, and
this association might not depend on the concentrations
of anti-CCP antibodies or RF. Thus, TRAF1/C5 is
another locus playing a role in RA development in dif-
ferent ethnicities. We observed that rs3761847 A
increased the risk for RA in the present study, which is
consistent with the results observed in a Japanese popu-
lation [30], however, this is the opposite of the original
studies in Caucasian populations, in which rs3761847 A
decreased the risk of RA. In addition, rs3761847 did not
show a significant association with RA in the Korean
population [20,30]. On theo t h e rh a n d ,w ef o u n dt h a t
rs7021206 at intron 3 of TRAF1 was showed significant
association with RA in the Han Chinese in this study,
which is consistent with previous studies in Korean and
Caucasian populations [20]. This indicated that
rs7021206, but not rs376184, may be the true causative
allele at the TRAF1-C5 locus [20,47]; However, the true
causative allele in this region needs to be further
investigated.
The significant association between rs3761847 and RA
was observed in both anti-CCP and RF positive groups
and negative groups, suggesting that this significant
association between TRAF1-C1 and RA was indepen-
dent of the concentrations of anti-CCP and RF [20]. No
significant association was observed between rs7021206
and RA in anti-CCP and RF negative groups; this may
be because of small sample size in these groups in the
current studies.
Other studies indicate genetic variants at the TRAF1/
C5 locus are associated with autoimmune diseases affect-
ing multiple organs, such as systemic lupus erythematous
(SLE) [48,49], and juvenile idiopathic arthritis [50-52].
Thus, the functional study of TRAF1/C5 with autoim-
mune disease may provide an insight into the pathogen-
esis and treatment of these diseases as well as RA.
Conclusions
We first demonstrated that genetic variants rs3761847
and rs7021206 in TRAF1/C5 locus are significantly asso-
ciated with RA in the Han Chinese, suggesting that
TRAF1/C5 may play a role in the development RA in
this population, which expands the pathogenesis role of
TRAF1/C5 in a different ethnicity. Unlike in Caucasian
populations, rs2476601 in the PTPN22 gene did not
show polymorphism in the Han Chinese population
being studied, suggesting that either other genetic var-
iants in this gene are associated with RA in the Han
Chinese population or PTPN22 has nothing to do with
RA the population.
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